• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

确定用于遗传性血管性水肿评估和诊断的生物标志物。

Determining biomarkers for evaluation and diagnosis of hereditary angioedema.

作者信息

Singh Umesh, Bernstein Jonathan A

机构信息

University of Cincinnati College of Medicine Cincinnati Ohio USA.

出版信息

Clin Transl Allergy. 2022 Oct 12;12(10):e12202. doi: 10.1002/clt2.12202. eCollection 2022 Oct.

DOI:10.1002/clt2.12202
PMID:36254341
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9557132/
Abstract

RATIONALE

Kallikrein-bradykinin-forming cascade is known to cause hereditary angioedema (HAE) acute angioedema (AE) attacks. Further research of HAE attacks is needed to explain disease heterogeneity, predict treatment response and identify biomarkers for monitoring HAE attacks. Differential expression of the microvascular endothelial cell-surface receptors for example, g-C1qR, cytokeratin-1, and plasminogen-activator-urokinase-receptor (PLAUR) were hypothesized as biomarkers of AE attacks.

METHOD

To understand HAE attacks, the differentially expressed genes (DEGs) in RNAseq and mi-RNAseq data of total RNA extracted from skin biopsies of lesional versus non-lesional skin collected during and between attacks in Type-1 HAE patients ( = 11; F:M = 8:3) were compared. To understand the HAE variants, DEGs in skin biopsies from HAE with normal C1 inhibitor ( = 5, F:M = 5:0), and non-HAE ( = 7; F:M = 3:4) patients were compared. Gene-set enrichment analyses and regulator effects analysis of these DEGs identified biological pathways in HAE attacks and their regulators.

RESULTS

PLAUR gene, encoding urokinase-type plasminogen activator (u-PAR), was constitutively over-expressed in HAE-Type-1 versus non-HAE controls suggestive of overactive u-PAR-mediated signaling via binding to Factor-XII. Baseline PLAUR expression was associated with severe AE ( = 0.05). The 18 significant DEGs investigated between baseline and AE attack samples in Type1-HAE were enriched in beta1/beta3-integrin cell surface interactions and IL-6-mediated signaling. Regulator effects analysis suggests a role for IL-1b in HAE flares. AKT2, the mRNA regulated by the differentially-expressed miR-184A, was also associated with HAE attacks.

CONCLUSION

Angiopoetin-activated 1-integrin signaling pathways causing endothelial destabilization, and avid binding of factor XII to u-PAR are possible novel mechanisms for progression of the endothelial kinin-bradykinin-forming cascade in HAE attacks.

摘要

原理

已知激肽释放酶-缓激肽形成级联反应会引发遗传性血管性水肿(HAE)急性血管性水肿(AE)发作。需要对HAE发作进行进一步研究,以解释疾病异质性、预测治疗反应并确定监测HAE发作的生物标志物。微血管内皮细胞表面受体(例如,g-C1qR、细胞角蛋白-1和纤溶酶原激活物-尿激酶受体(PLAUR))的差异表达被假定为AE发作的生物标志物。

方法

为了解HAE发作情况,比较了1型HAE患者(n = 11;女性:男性 = 8:3)在发作期间和发作间隔期从病变皮肤与非病变皮肤活检组织中提取的总RNA的RNA测序和微小RNA测序数据中的差异表达基因(DEG)。为了解HAE变体,比较了C1抑制剂正常的HAE患者(n = 5;女性:男性 = 5:0)和非HAE患者(n = 7;女性:男性 = 3:4)皮肤活检组织中的DEG。对这些DEG进行基因集富集分析和调节因子效应分析,确定了HAE发作中的生物途径及其调节因子。

结果

编码尿激酶型纤溶酶原激活物(u-PAR)的PLAUR基因在1型HAE中与非HAE对照相比持续过度表达,提示通过与因子XII结合,u-PAR介导的信号传导过度活跃。基线PLAUR表达与严重AE相关(P = 0.05)。在1型HAE基线样本与AE发作样本之间研究的18个显著DEG富含β1/β3整合素细胞表面相互作用和IL-6介导的信号传导。调节因子效应分析表明IL-1b在HAE发作中起作用。由差异表达的miR-184A调节的mRNA AKT2也与HAE发作相关。

结论

血管生成素激活的1-整合素信号通路导致内皮细胞不稳定,以及因子XII与u-PAR的强烈结合,可能是HAE发作中内皮激肽释放酶-缓激肽形成级联反应进展的新机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/45314853dbc7/CLT2-12-e12202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/4d6cc8e35c69/CLT2-12-e12202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/287e19bbcc18/CLT2-12-e12202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/935e3d4a5dfd/CLT2-12-e12202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/5d66b152b160/CLT2-12-e12202-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/45314853dbc7/CLT2-12-e12202-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/4d6cc8e35c69/CLT2-12-e12202-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/287e19bbcc18/CLT2-12-e12202-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/935e3d4a5dfd/CLT2-12-e12202-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/5d66b152b160/CLT2-12-e12202-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ea7/9557132/45314853dbc7/CLT2-12-e12202-g003.jpg

相似文献

1
Determining biomarkers for evaluation and diagnosis of hereditary angioedema.确定用于遗传性血管性水肿评估和诊断的生物标志物。
Clin Transl Allergy. 2022 Oct 12;12(10):e12202. doi: 10.1002/clt2.12202. eCollection 2022 Oct.
2
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.缓激肽介导疾病的发病机制:固有炎症途径的失调。
Adv Immunol. 2014;121:41-89. doi: 10.1016/B978-0-12-800100-4.00002-7.
3
Systemic inflammation biomarkers during angioedema attacks in hereditary angioedema.遗传性血管性水肿发作期间的全身性炎症生物标志物。
Front Immunol. 2024 Jun 17;15:1400526. doi: 10.3389/fimmu.2024.1400526. eCollection 2024.
4
A transcriptomics study of hereditary angioedema attacks.遗传性血管性水肿发作的转录组学研究。
J Allergy Clin Immunol. 2018 Sep;142(3):883-891. doi: 10.1016/j.jaci.2018.03.016. Epub 2018 May 4.
5
Hereditary angioedema in childhood: an approach to management.儿童遗传性血管性水肿:管理方法。
Paediatr Drugs. 2010 Aug 1;12(4):257-68. doi: 10.2165/11532590-000000000-00000.
6
Treatment of hereditary angioedema-single or multiple pathways to the rescue.遗传性血管性水肿的治疗——单途径或多途径救援
Front Allergy. 2022 Sep 12;3:952233. doi: 10.3389/falgy.2022.952233. eCollection 2022.
7
Angioedema Without Wheals: Challenges in Laboratorial Diagnosis.无风团性血管性水肿:实验室诊断的挑战。
Front Immunol. 2021 Dec 8;12:785736. doi: 10.3389/fimmu.2021.785736. eCollection 2021.
8
Measurement of Bradykinin Formation and Degradation in Blood Plasma: Relevance for Acquired Angioedema Associated With Angiotensin Converting Enzyme Inhibition and for Hereditary Angioedema Due to Factor XII or Plasminogen Gene Variants.血浆中缓激肽生成与降解的测定:与血管紧张素转换酶抑制相关的获得性血管性水肿以及因因子 XII 或纤溶酶原基因变异导致的遗传性血管性水肿的相关性
Front Med (Lausanne). 2020 Jul 17;7:358. doi: 10.3389/fmed.2020.00358. eCollection 2020.
9
Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels.C1抑制剂水平正常的遗传性血管性水肿患者血浆中纤溶酶原激活物抑制剂2缺乏
J Allergy Clin Immunol. 2016 Jun;137(6):1822-1829.e1. doi: 10.1016/j.jaci.2015.07.041. Epub 2015 Sep 26.
10
High-molecular-weight kininogen cleavage correlates with disease states in the bradykinin-mediated angioedema due to hereditary C1-inhibitor deficiency.在由遗传性C1抑制物缺乏引起的缓激肽介导的血管性水肿中,高分子量激肽原的裂解与疾病状态相关。
Clin Exp Allergy. 2014 Dec;44(12):1503-14. doi: 10.1111/cea.12293.

引用本文的文献

1
Hereditary angioedema plasma proteomics following specific plasma kallikrein inhibition with lanadelumab.使用拉那度单抗特异性抑制血浆激肽释放酶后遗传性血管性水肿的血浆蛋白质组学
Front Immunol. 2025 May 9;15:1471168. doi: 10.3389/fimmu.2024.1471168. eCollection 2024.

本文引用的文献

1
Does hereditary angioedema make COVID-19 worse?遗传性血管性水肿会使新冠病毒疾病病情加重吗?
World Allergy Organ J. 2020 Sep;13(9):100454. doi: 10.1016/j.waojou.2020.100454. Epub 2020 Aug 10.
2
An update on the genetics and pathogenesis of hereditary angioedema.遗传性血管性水肿的遗传学与发病机制最新进展
Genes Dis. 2019 Aug 1;7(1):75-83. doi: 10.1016/j.gendis.2019.07.002. eCollection 2020 Mar.
3
Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation.缓激肽受体:激动剂、拮抗剂、表达、信号传导及对持续刺激的适应性
Int Immunopharmacol. 2020 Feb 24;82:106305. doi: 10.1016/j.intimp.2020.106305.
4
Oxidative stress in hereditary angioedema caused by C1 inhibitor deficiency: an interesting finding that deserves further studies.C1抑制剂缺乏所致遗传性血管性水肿中的氧化应激:一项值得进一步研究的有趣发现。
Pol Arch Intern Med. 2020 Feb 27;130(2):73-75. doi: 10.20452/pamw.15213.
5
Adipose PTEN regulates adult adipose tissue homeostasis and redistribution via a PTEN-leptin-sympathetic loop.脂肪组织中的 PTEN 通过 PTEN-瘦素-交感神经环路调节成年脂肪组织的稳态和再分布。
Mol Metab. 2019 Dec;30:48-60. doi: 10.1016/j.molmet.2019.09.008. Epub 2019 Sep 28.
6
IL-1 Family Cytokine Regulation of Vascular Permeability and Angiogenesis.IL-1 家族细胞因子对血管通透性和血管生成的调节。
Front Immunol. 2019 Jun 25;10:1426. doi: 10.3389/fimmu.2019.01426. eCollection 2019.
7
Oxidative stress markers in patients with hereditary angioedema.遗传性血管性水肿患者的氧化应激标志物
Arch Med Sci. 2019 Jan;15(1):92-98. doi: 10.5114/aoms.2017.66160. Epub 2017 Jul 31.
8
Cytokine and estrogen stimulation of endothelial cells augments activation of the prekallikrein-high molecular weight kininogen complex: Implications for hereditary angioedema.细胞因子和雌激素刺激内皮细胞可增强前激肽释放酶-高分子量激肽原复合物的激活:对遗传性血管性水肿的影响。
J Allergy Clin Immunol. 2017 Jul;140(1):170-176. doi: 10.1016/j.jaci.2016.09.032. Epub 2016 Nov 5.
9
Macrophages: An Inflammatory Link Between Angiogenesis and Lymphangiogenesis.巨噬细胞:血管生成与淋巴管生成之间的炎症联系
Microcirculation. 2016 Feb;23(2):95-121. doi: 10.1111/micc.12259.
10
Growth factors and IL-17 in hereditary angioedema.遗传性血管性水肿中的生长因子与白细胞介素-17
Clin Exp Med. 2016 May;16(2):213-8. doi: 10.1007/s10238-015-0340-y. Epub 2015 Mar 15.